Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Oct;46(5):343-344.
doi: 10.1016/j.diabet.2020.06.003. Epub 2020 Jun 17.

SGLT2 inhibition during the COVID-19 epidemic: Friend or foe?

Affiliations
Editorial

SGLT2 inhibition during the COVID-19 epidemic: Friend or foe?

A J Scheen. Diabetes Metab. 2020 Oct.
No abstract available

Keywords: Adipose tissue; COVID-19; Inflammation; Ketoacidosis; SGLT2 inhibitor.

PubMed Disclaimer

Comment on

References

    1. Targher G., Mantovani A., Wang X.B., Yan H.D., Sun Q.F., Pan K.H. Patients with diabetes are at higher risk for severe illness from COVID-19. Diabetes Metab. 2020 doi: 10.1016/j.diabet.2020.05.001. S1262-3636(20)30075-6. - DOI - PMC - PubMed
    1. Scheen A.J., Marre M., Thivolet C. Prognostic factors in patients with diabetes hospitalized for COVID-19: findings from the CORONADO study and recent reports. Diabetes Metab. 2020 doi: 10.1016/j.diabet.2020.05.008. S1262-3636(20)30085-9. - DOI - PMC - PubMed
    1. Bonnet F., Scheen A.J. Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: potential contribution for diabetic complications and cardiovascular disease. Diabetes Metab. 2018;44:457–464. - PubMed
    1. Xu L., Ota T. Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: Focus on fat browning and macrophage polarization. Adipocyte. 2018;7:121–128. - PMC - PubMed
    1. Ryan P.M., Caplice N.M. Is adipose tissue a reservoir for viral spread, immune activation and cytokine amplification in COVID-19. Obesity. 2020 doi: 10.1002/oby.22843. Online ahead of print. - DOI - PMC - PubMed

Substances